Co-Authors
This is a "connection" page, showing publications co-authored by Charlie Strange and Chitra Lal.
Connection Strength
4.766
-
Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States. Sleep Breath. 2020 Sep; 24(3):985-993.
Score: 0.654
-
Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opin Pharmacother. 2019 Jun; 20(9):1075-1085.
Score: 0.635
-
Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome. Sleep Breath. 2019 Mar; 23(1):251-257.
Score: 0.602
-
A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD. Expert Opin Pharmacother. 2017 Dec; 18(17):1833-1843.
Score: 0.576
-
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:135-140.
Score: 0.542
-
Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2015 Feb; 16(3):427-34.
Score: 0.475
-
Impact of medications on cognitive function in obstructive sleep apnea syndrome. Sleep Breath. 2015 Sep; 19(3):939-45.
Score: 0.473
-
Unilateral pulmonary artery aplasia in a pregnant patient. Case Rep Med. 2011; 2011:806723.
Score: 0.364
-
A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South Carolina. J Clin Sleep Med. 2021 03 01; 17(3):367-374.
Score: 0.181
-
Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women. Sleep Breath. 2016 May; 20(2):621-6.
Score: 0.124
-
Effect of obstructive sleep apnea treatment on mail-in cognitive function screening instrument. Am J Med Sci. 2014 Sep; 348(3):215-8.
Score: 0.115
-
Neurocognitive impairment in obstructive sleep apnea. Chest. 2012 Jun; 141(6):1601-1610.
Score: 0.025